drugset / Trial / NCT00185419

A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception

NCT00185419

Phase 3 Completed 842 enrolled Bayer
RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to evaluate the effectiveness in terms of prevention of pregnancy and safety of the oral contraceptive Yasmin and Marvelon on cycle control in healthy Chinese women

Timeline

Start
2003-11
Primary completion
2006-03
Completion
2006-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Desogestrel Small molecule 150 ug Oral
Subject drospirenone Unknown 3 mg Oral
Subject ethinyl estradiol Small molecule 30 ug Oral

Indications

No indication recorded.